People
Life sciences companies strengthen their leadership teams with this week’s appointments.
The agency found that more than 2.8 million antibiotic-resistant infections occurred in the U.S. each year, killing more than 35,000 people.
Miles D. White will step down from his role as CEO following 21 years with the company. He will be succeeded by another long-time Abbott veteran, Robert B. Ford, who has been with the company for 23 years.
Orion Biotechnology Canada Ltd. announced that Dr. Thomas Hecht has been appointed Chairman of its Board of Directors.
Mongeau to leverage experience and relationships in the space to lead sleep and respiratory divisions’ continued national growth
Outstanding dedication to quality, science and customer service helped RSSL secure Best Contract Research Organisation at this year’s Oxford Bioscience Network (OBN) Awards.
Lonza announced that Marc Funk, CEO, will leave the Company for personal reasons. The Board of Directors also announced that Albert Baehny, Chairman, will take on the additional responsibility of Chief Executive Officer on an ad interim basis until a permanent successor is found.
Ellume Limited is pleased to announce the appointment of Ms Joanne Moss to its Board as an Independent Non-Executive Director and Chair of Audit and Risk, effective immediately.
Rho’s Kristin Gabor was honored on November 8 at the Cystic Fibrosis Foundation’s annual “Brewer’s Ball Celebrating Triangle’s Finest” event that took place at The Rickhouse in Durham.
The World Anti-Microbial Resistance Congress 2019 was held November 7-8 in Washington, D.C.
PRESS RELEASES